FGFR4 and malignant colon neoplasm: In another investigation focused on FGFR4 missense variant, the GG of FGFR4 rs351855 (Gly 388 Arg) showed significantly better overall survival than the AG or AA among 273 colon cancer patients, regardless of adjuvant treatment [47].